摘要
新型冠状病毒肺炎自发现以来,具有发病急、传变快、明显传染性等特点,属中医研究疫病范畴。目前,中医治疗新型冠状病毒肺炎已取得良好成效。由于新型冠状病毒肺炎的病机和证候与温热病大致相符,因此可以从温热病角度分析,而卫气营血辨证是温病学中的重要理论基础,通过卫气营血辨证可解释其传变规律、证候等特征,为新型冠状病毒肺炎诊治带来更多的可能。回顾卫气营血辨证的演变历史,基于《温热论》,将温病由轻到重的症状分为四个阶段,分析新型冠状病毒肺炎的病机特点,同时结合卫气营血辨证阐释新型冠状病毒肺炎的传变规律,将新型冠状病毒肺炎不同阶段的免疫状态与卫气营血四个阶段的证候特征相联系,总结运用卫气营血辨证在中西医结合治疗新型冠状病毒肺炎中的影响意义,为诊治新型冠状病毒肺炎提供更多的思路。
Since the discovery of COVID-19,it has been characterized by rapid onset,rapid transmission and obvious infectivity,which belongs to the category of epidemic diseases studied in traditional Chinese medicine.At present,traditional Chinese medicine has demonstrated promising results in the treatment of COVID-19.Since the pathogenesis and syndrome of COVID-19 are roughly consistent with febrile disease,it can be analyzed from the perspective of febrile disease from the view of traditional Chinese medicine.As is well known,Wei-Qi-Ying-Xue is an important theoretical basis in febrile disease.The law of transmission and syndrome characteristics can be explained through the syndrome differentiation of Wei-Qi-Ying-Xue,which brings more possibilities for the diagnosis and treatment of COVID-19.Reviewed the evolution history of syndrome differentiation of Wei-Qi-Ying-Xue,based on TREATISE ON EPIDEMIC FEBRILE DISEASES,epidemic febrile disease from light to heavy symptoms was divided into four stages,and the pathogenesis characteristics of COVID-19 were analyzed.Combined with syndrome differentiation of Wei-Qi-Ying-Xue,this review interpreted the change law of COVID-19.The immune status in different stages of COVID-19 was associated with the syndrome characteristics of four stages of Wei-Qi-Ying-Xue.This review also summarized the significance of application of Wei-Qi-Ying-Xue in the treatment of COVID-19,combining traditional Chinese and western medicine,so as to provide more references for the diagnosis and treatment of COVID-19.
作者
梁瀚兮(综述)
张耀丹(审校)
LIANG Hanxi;ZHANG Yaodan(Department of Clinical Medicine,Chengdu Medical College,Chengdu 610500,China;Department of Neurology,the Affiliated Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu 610072,China)
出处
《西南医科大学学报》
2022年第6期545-548,共4页
Journal of Southwest Medical University
基金
国家自然科学基金面上项目(81973732)
南充市市校科技战略合作项目(19SXHZ0181)
南充市社科研究“十三五”规划项目(NC2019B021)
关键词
新型冠状病毒肺炎
温病学
卫气营血辨证
免疫调节
COVID-19
Epidemic febrile disease
Syndrome differentiation of Wei-Qi-Ying-Xue
Immunoregulation